How Far Are ADCs from Treating Prostate Cancer?

How Far Are ADCs from Treating Prostate Cancer?

Antibody-drug conjugates (ADCs) have emerged as a significant platform for precision oncology, demonstrating remarkable efficacy in various solid tumors in recent years. With ongoing innovations in target selection and linker technology, the development of ADCs for the treatment of metastatic castration-resistant prostate cancer (mCRPC) has also made significant strides. This article systematically reviews the latest … Read more

Precision Minimally Invasive Surgery: Safeguarding Life’s Glands

Precision Minimally Invasive Surgery: Safeguarding Life's Glands

Precision Minimally Invasive Surgery: Safeguarding Life’s Glands —Da Vinci Robot-Assisted Radical Prostatectomy On the morning of September 1, Mr. Zhang (pseudonym), a patient, received a banner from his daughter to express gratitude to Director Yan Chengquan, Dr. Meng Xin, and all medical staff of the Urology Department III at Tangshan Workers’ Hospital! Mr. Zhang (pseudonym) … Read more

2022 ASCO | Professor Xing Nianzeng: mHSPC Research Progress Interpretation

2022 ASCO | Professor Xing Nianzeng: mHSPC Research Progress Interpretation

Introduction The American Society of Clinical Oncology (ASCO) annual meeting is the largest and most authoritative clinical oncology conference in the world, with nearly 40,000 experts from over 100 countries participating. The focus is on cancer-related research, showcasing representative basic and clinical studies, and discussing current international advanced treatment methods. This year’s conference featured 234 … Read more

Clinical Results of Targeting Prostate Cancer with ADCs

Clinical Results of Targeting Prostate Cancer with ADCs

Important targets for targeting prostate cancer (PCa) include: prostate-specific membrane antigen (PSMA), six-transmembrane epithelial antigen 1 (STEAP-1), solute carrier family 44 member 4 (SLC44A4), trophoblast cell surface antigen (Trop-2) and B7-H3. Introduction Antibody-drug conjugates (ADCs) consist of a linker, payload, and monoclonal antibody (mAb). They combine the advantages of high specificity targeting and potent killing … Read more

Understanding Robotic Surgery: Innovations and Insights

Understanding Robotic Surgery: Innovations and Insights

Introduction: As one of the important components of the 2024 Service Trade Fair, the National Health Commission’s People’s Health Channel (CHTV) is scheduled to hold the “Parallel Forum of the 2024 Capital International Medical Conference – Smart Medical and Medical Artificial Intelligence Innovation Forum” on September 13 in Beijing. CHTV & Medical Forum Network will … Read more

The Value of miPSMA Scoring in Diagnosing Prostate Cancer Using (68)Ga-PSMA-11 PET/CT Imaging

The Value of miPSMA Scoring in Diagnosing Prostate Cancer Using (68)Ga-PSMA-11 PET/CT Imaging

Source Liu Yachao, Cheng Nuo, Li Yungang, et al. The Value of (68)Ga-PSMA-11 PET/CT Imaging Application of miPSMA Scoring in Diagnosing Prostate Cancer. Chinese Journal of Medical Imaging, 2021, 29(01): 47-50+55 Abstract Objective To explore the diagnostic efficacy of molecular imaging prostate-specific membrane antigen (miPSMA) scoring for prostate cancer, and whether the maximum standardized uptake … Read more

Da Vinci Surgical Robot System

Da Vinci Surgical Robot System

In recent years, robot-assisted technology has gradually been applied more and more in urological surgeries, making it possible to perform more precise and complex operations. The Da Vinci Surgical System integrates three main features: 3D high-definition vision, wristed surgical instruments, and intuitive motion control, allowing surgeons to apply minimally invasive techniques more widely in complex … Read more